These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28882024)

  • 21. [Association between retinopathy and sleep disorder in patients with type 2 diabetes mellitus].
    Ren H; Xu Y; Chang B; Yang J; Zheng M; Yang Y; Cheng J; Shan C
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2579-83. PubMed ID: 26711603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity dysregulates fasting-induced changes in glucagon secretion.
    Stern JH; Smith GI; Chen S; Unger RH; Klein S; Scherer PE
    J Endocrinol; 2019 Nov; 243(2):149-160. PubMed ID: 31454790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance.
    Miyake CNH; Gualano B; Dantas WS; Pereira RT; Neves W; Zambelli VO; Shinjo SK; Pereira RM; Silva ER; Sá-Pinto AL; Borba E; Roschel H; Bonfá E; Benatti FB
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):114-124. PubMed ID: 28320046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.
    Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP
    Neth J Med; 1999 Feb; 54(2):63-9. PubMed ID: 10079680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
    Ahrén B; Landin-Olsson M; Jansson PA; Svensson M; Holmes D; Schweizer A
    J Clin Endocrinol Metab; 2004 May; 89(5):2078-84. PubMed ID: 15126524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects.
    Cersosimo E; Gastaldelli A; Cervera A; Wajcberg E; Sriwijilkamol A; Fernandez M; Zuo P; Petz R; Triplitt C; Musi N; DeFronzo RA
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1763-70. PubMed ID: 21411546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes.
    Halden TA; Egeland EJ; Åsberg A; Hartmann A; Midtvedt K; Khiabani HZ; Holst JJ; Knop FK; Hornum M; Feldt-Rasmussen B; Jenssen T
    Diabetes Care; 2016 Apr; 39(4):617-24. PubMed ID: 26908914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon/insulin ratio in preoperative screening before pancreatic surgery: correlation with hemoglobin A1C in subjects with and without pancreatic cancer.
    Jin SM; Choi SH; Choi DW; Heo JS; Suh S; Bae JC; Kim JH; Lee MS; Kim KW; Lee MK
    Endocrine; 2014 Nov; 47(2):493-9. PubMed ID: 24452875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations.
    Rodrigues MR; Santo MA; Favero GM; Vieira EC; Artoni RF; Nogaroto V; de Moura EG; Lisboa P; Milleo FQ
    World J Gastroenterol; 2015 Jun; 21(22):6990-8. PubMed ID: 26078577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials.
    Ahrén B; Gautier JF; Berria R; Stager W; Aronson R; Bailey CJ
    Diabetes Obes Metab; 2014 Sep; 16(9):861-8. PubMed ID: 24641271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: The role of glucagon in postprandial hyperglycemia--the jury's still out.
    Bollyky J; Greenbaum CJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2879-81. PubMed ID: 17682088
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
    Vilsbøll T; Krarup T; Deacon CF; Madsbad S; Holst JJ
    Diabetes; 2001 Mar; 50(3):609-13. PubMed ID: 11246881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.
    Ahrén B; Schweizer A; Dejager S; Dunning BE; Nilsson PM; Persson M; Foley JE
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1236-43. PubMed ID: 19174497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive correlation between serum IGF-1 and HDL-C in type 2 diabetes mellitus.
    Song X; Teng J; Wang A; Li X; Wang J; Liu Y
    Diabetes Res Clin Pract; 2016 Aug; 118():44-9. PubMed ID: 27322526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
    Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
    Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter study.
    Mo Y; Ma X; Li H; Ran X; Yang W; Li Q; Peng Y; Li Y; Gao X; Luan X; Wang W; Xie Y; Zhou J; Jia W
    Diabetes Res Clin Pract; 2016 May; 115():17-23. PubMed ID: 27242118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects.
    Brader L; Holm L; Mortensen L; Thomsen C; Astrup A; Holst JJ; de Vrese M; Schrezenmeir J; Hermansen K
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):101-9. PubMed ID: 19473824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD; Manson JE; Meigs JB; Rifai N; Buring JE; Liu S; Ridker PM
    Am J Med; 2003 Apr; 114(6):438-44. PubMed ID: 12727576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels.
    Zhang JP; Wang N; Xing XY; Yang ZJ; Wang X; Yang WY
    J Diabetes; 2016 Jul; 8(4):559-67. PubMed ID: 26331290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.